ATE381933T1 - Medizinische zusammensetzungen enthaltend n-(3- chloro-1h-indol-7-yl)-4-sulfamoylbenzensulfonam d und weitere cytostatika - Google Patents

Medizinische zusammensetzungen enthaltend n-(3- chloro-1h-indol-7-yl)-4-sulfamoylbenzensulfonam d und weitere cytostatika

Info

Publication number
ATE381933T1
ATE381933T1 AT04730660T AT04730660T ATE381933T1 AT E381933 T1 ATE381933 T1 AT E381933T1 AT 04730660 T AT04730660 T AT 04730660T AT 04730660 T AT04730660 T AT 04730660T AT E381933 T1 ATE381933 T1 AT E381933T1
Authority
AT
Austria
Prior art keywords
indol
chloro
sulfamoylbenzenesulfonam
cytostatics
compositions containing
Prior art date
Application number
AT04730660T
Other languages
English (en)
Inventor
Yoichi Ozawa
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/431,569 external-priority patent/US20030215523A1/en
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Application granted granted Critical
Publication of ATE381933T1 publication Critical patent/ATE381933T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT04730660T 2003-05-08 2004-04-30 Medizinische zusammensetzungen enthaltend n-(3- chloro-1h-indol-7-yl)-4-sulfamoylbenzensulfonam d und weitere cytostatika ATE381933T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/431,569 US20030215523A1 (en) 2000-10-31 2003-05-08 Medicinal compositions for concomitant use as anticancer agent

Publications (1)

Publication Number Publication Date
ATE381933T1 true ATE381933T1 (de) 2008-01-15

Family

ID=33434857

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04730660T ATE381933T1 (de) 2003-05-08 2004-04-30 Medizinische zusammensetzungen enthaltend n-(3- chloro-1h-indol-7-yl)-4-sulfamoylbenzensulfonam d und weitere cytostatika

Country Status (9)

Country Link
EP (1) EP1622624B1 (de)
JP (1) JP2006525321A (de)
KR (1) KR20060007368A (de)
CN (1) CN100352446C (de)
AT (1) ATE381933T1 (de)
AU (1) AU2004235687A1 (de)
CA (1) CA2518076A1 (de)
DE (1) DE602004010900D1 (de)
WO (1) WO2004098613A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009501734A (ja) * 2005-07-21 2009-01-22 ヌボ・リサーチ・インコーポレイテッド 癌の治療方法
EP2747571A4 (de) * 2011-08-24 2015-05-27 David Kerr Niedrigdosierte kombinationschemotherapie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3545461B2 (ja) * 1993-09-10 2004-07-21 エーザイ株式会社 二環式ヘテロ環含有スルホンアミド誘導体
TWI283575B (en) * 2000-10-31 2007-07-11 Eisai Co Ltd Medicinal compositions for concomitant use as anticancer agent

Also Published As

Publication number Publication date
EP1622624A1 (de) 2006-02-08
WO2004098613A1 (en) 2004-11-18
KR20060007368A (ko) 2006-01-24
CN100352446C (zh) 2007-12-05
JP2006525321A (ja) 2006-11-09
DE602004010900D1 (de) 2008-02-07
CA2518076A1 (en) 2004-11-18
AU2004235687A1 (en) 2004-11-18
EP1622624B1 (de) 2007-12-26
CN1780629A (zh) 2006-05-31

Similar Documents

Publication Publication Date Title
ATE322264T1 (de) Medizinische zusammensetzungen als begleittherapie gegen krebs
ATE433447T1 (de) Pyrimiidinverbindungen
ATE353888T1 (de) Chinazolinderivate
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
UA91002C2 (ru) 7-фенилалкилзамещенные 2-хинолиноны и 2-хиноксалиноны как ингибиторы поле(адф-рибоза)полимеразы
IS6658A (is) Ný efnasambönd
BR0308081A (pt) Inibidores de histona desacetilase
EA200601002A1 (ru) 6-алкенил и 6-фенилалкил замещённые 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза) полимеразы
SE0302139D0 (sv) Novel compounds
DE60212949D1 (de) Antivirale pyrazolopyridin verbindungen
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
TW200604197A (en) New compounds
UY29999A1 (es) "n-pirazinil-fenilsulfonamidas, procedimientos y compuestos intemedios utilizados en su preparacion, composiciones farmaceuticas que las contienen y aplicaciones"
PL1753719T3 (pl) Podstawione pirolidyn-2-ony
TR200101978T2 (tr) 3,3-Biarilpiperidin ve 2,2-biarilmorfolin türevleri.
RU2003103101A (ru) Плеуромутилиновые производные, обладающие антибактериальной активностью
SE0101038D0 (sv) Novel compounds
SE0300456D0 (sv) Novel compounds
SE0303280D0 (sv) Novel compounds
ATE497967T1 (de) Interzelluläre kommunikation erleichternden verbindungen und deren medizinischen verwendungen
IL172538A0 (en) Depsipeptide compounds, pharmaceutical compositions containing the same and processes for the preparation thereof
SE0303090D0 (sv) Novel compounds
ATE381933T1 (de) Medizinische zusammensetzungen enthaltend n-(3- chloro-1h-indol-7-yl)-4-sulfamoylbenzensulfonam d und weitere cytostatika
DE602004021363D1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties